A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib

Clinical trial NCT04640025 · TERMINATED

Trial details

NCT number: NCT04640025
Sponsor: Incyte Corporation
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Postlung Transplant (Bronchiolitis Obliterans)Chronic Graft Versus Host Disease

Start date: 2021-03-10
Primary completion: 2026-05-11
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.